| Literature DB >> 25035714 |
Gerardo Alvarez-Uria1, Seeba Zachariah2, Dixon Thomas3.
Abstract
BACKGROUND: The World Health Organization (WHO) recommends surveillance of antibiotic use as part of the strategy to fight against antimicrobial resistance. However, there is little information about the antibiotic consumption in developing countries, especially in rural areas.Entities:
Keywords: Anti-Bacterial Agents; Bacterial; Drug Resistance; Drug Utilization; Inappropriate Prescribing; India; Rural Health
Year: 2014 PMID: 25035714 PMCID: PMC4100948 DOI: 10.4321/s1886-36552014000200003
Source DB: PubMed Journal: Pharm Pract (Granada) ISSN: 1885-642X
Description of the total antibiotic consumption and by hospital departments.
| Total | Medicine | O&G | Surgery | |
|---|---|---|---|---|
| Inpatients | ||||
| Admissions (N) | 15735 | 2901 | 9575 | 3259 |
| Any antibiotic (%) | 86 | 62.9 | 92.2 | 88.4 |
| N of antibiotics (mean) | 1.81 | 2.2 | 1.67 | 1.99 |
| Days of admission (mean) | 3.1 | 4.3 | 2.5 | 3.9 |
| DDDs/100 patient-days | 221.9 | 153.2 | 294.8 | 150.8 |
| DDDs/100 admissions | 692.5 | 652.3 | 739.7 | 589.5 |
| Outpatients | ||||
| Visits (N) | 250611 | 120241 | 88264 | 42106 |
| Any antibiotic (%) | 12.5 | 14.91 | 8.98 | 13.04 |
| N of antibiotics (mean) | 1.21 | 1.18 | 1.24 | 1.26 |
| DDDs/100 visits | 86.16 | 104.68 | 58.47 | 91.31 |
DDDs; defined daily doses; N, number; O&G, Obstetrics and Gynaecology.
Description of the most utilized antibiotics (drug utilization 90%) in inpatients and outpatients.
| antibiotic group | DDDs/100 patient-days (IP) | DDDs/100 admissions (IP) | DDDs/100 outpatient visits | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Med | O&G | Surg | Total | Med | O&G | Surg | Total | Med | O&G | Surg | |
| Aminopenicillins | 171.73 | 11.07 | 313.43 | 60.32 | 536.02 | 47.13 | 786.33 | 235.79 | 18.03 | 18.05 | 8.6 | 37.75 |
| Aminopenicillin & enzyme inhibitor | 19.95 | 39.6 | 3.55 | 31.82 | 62.27 | 168.62 | 8.91 | 124.36 | 20.23 | 25.27 | 5.17 | 37.41 |
| 3rd generation cephalosporins | 76.94 | 47.15 | 117.54 | 29.28 | 240.16 | 200.78 | 294.89 | 114.44 | 17.43 | 20.45 | 15.23 | 13.4 |
| Lincosamides | 1.41 | 2.17 | 0.23 | 2.91 | 4.41 | 9.23 | 0.57 | 11.38 | 0.05 | 0.03 | 0.03 | 0.13 |
| Tetracyclines | 17.06 | 59.75 | 2.84 | 2.48 | 53.26 | 254.46 | 7.12 | 9.7 | 47.28 | 67.1 | 29.14 | 28.7 |
| Imidazoles | 23.61 | 22.74 | 13.94 | 42.67 | 73.68 | 96.86 | 34.98 | 166.78 | 16.84 | 15.14 | 15.79 | 23.87 |
| Macrolides | 4.99 | 7.54 | 5.43 | 1.7 | 15.59 | 32.13 | 13.62 | 6.66 | 7.36 | 9 | 7.06 | 3.32 |
| Quinolones | 11.57 | 30.42 | 1.66 | 12 | 36.13 | 129.54 | 4.15 | 46.91 | 25.24 | 31.26 | 19.57 | 19.92 |
| Co-trimoxazole | 2.04 | 2.71 | 0.56 | 4.18 | 6.36 | 11.53 | 1.4 | 16.33 | 1.01 | 1.06 | 0.55 | 1.84 |
| Aminoglycosides | 9.44 | 9.55 | 4.09 | 19.41 | 29.46 | 40.67 | 10.26 | 75.89 | 0.3 | 0.31 | 0.09 | 0.69 |
DDDs, defined daily doses; IP, inpatients; Med, Medicine; O&G, Obstetrics and Gynaecology; Surg, Surgery.